These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37370184)

  • 1. Optimizing heart rate with ivabradine in heart failure with reduced ejection fraction: Insights from a post-hoc analysis of the SHIFT trial.
    Joury A
    Eur J Heart Fail; 2023 Aug; 25(8):1436-1438. PubMed ID: 37370184
    [No Abstract]   [Full Text] [Related]  

  • 2. A Review of New Pharmacologic Treatments for Patients With Chronic Heart Failure With Reduced Ejection Fraction.
    Nguyen E; Weeda ER; White CM
    J Clin Pharmacol; 2016 Aug; 56(8):936-47. PubMed ID: 26626162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac and Hemodynamic Benefits: Mode of Action of Ivabradine in Heart Failure.
    Pereira-Barretto AC
    Adv Ther; 2015 Oct; 32(10):906-19. PubMed ID: 26521191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction.
    Böhm M; Abdin A; Slawik J; Mahfoud F; Borer J; Ford I; Swedberg K; Tavazzi L; Batailler C; Komajda M
    Eur J Heart Fail; 2023 Aug; 25(8):1429-1435. PubMed ID: 37092340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Novel Treatment Approaches for Heart Failure With Reduced Ejection Fraction.
    Patel S; Veltri K
    J Pharm Pract; 2017 Oct; 30(5):541-548. PubMed ID: 27194070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited role and benefit of ivabradine in the treatment of angina and heart failure with reduced ejection fraction.
    Ennezat PV; Cosgrove S; Marechaux S; Bouvaist H; Le Jemtel TH; Vital Durand D
    Acta Cardiol; 2017 Dec; 72(6):664-668. PubMed ID: 28656798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ivabradine in Management of Heart Failure: a Critical Appraisal.
    Orasanu G; Al-Kindi SG; Oliveira GH
    Curr Heart Fail Rep; 2016 Feb; 13(1):60-9. PubMed ID: 26797824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety analysis of ivabradine hydrochloride treatment of Chinese patients with chronic heart failure: subgroup analysis of Chinese patients in the SHIFT study].
    Hu DY; Huang DJ; Yuan ZY; Zhao RP; Yan XW; Wang MH;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar; 45(3):190-197. PubMed ID: 28316174
    [No Abstract]   [Full Text] [Related]  

  • 9. Ivabradine in heart failure--no paradigm SHIFT…yet.
    Teerlink JR
    Lancet; 2010 Sep; 376(9744):847-9. PubMed ID: 20801501
    [No Abstract]   [Full Text] [Related]  

  • 10. Which place for ivabradine in Duchenne muscular dystrophy with heart failure?
    Fayssoil A
    Int J Cardiol; 2016 Nov; 223():768-769. PubMed ID: 27573604
    [No Abstract]   [Full Text] [Related]  

  • 11. Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.
    Bouabdallaoui N; O'Meara E; Bernier V; Komajda M; Swedberg K; Tavazzi L; Borer JS; Bohm M; Ford I; Tardif JC
    ESC Heart Fail; 2019 Dec; 6(6):1199-1207. PubMed ID: 31591826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ivabradine in Heart Failure: The Representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a Broad Population of Patients With Chronic Heart Failure.
    Das D; Savarese G; Dahlström U; Fu M; Howlett J; Ezekowitz JA; Lund LH
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28903983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rate and its reduction in chronic heart failure and beyond.
    Nikolovska Vukadinović A; Vukadinović D; Borer J; Cowie M; Komajda M; Lainscak M; Swedberg K; Böhm M
    Eur J Heart Fail; 2017 Oct; 19(10):1230-1241. PubMed ID: 28627045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel drugs for heart rate control in heart failure.
    Bielecka-Dabrowa A; von Haehling S; Rysz J; Banach M
    Heart Fail Rev; 2018 Jul; 23(4):517-525. PubMed ID: 29594814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use and Indication of Ivabradine in Heart Failure.
    Dodd K; Lampert BC
    Heart Fail Clin; 2018 Oct; 14(4):493-500. PubMed ID: 30266358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained-Release Ivabradine Hemisulfate in Patients With Systolic Heart Failure.
    Ye F; Wang X; Wu S; Ma S; Zhang Y; Liu G; Liu K; Yang Z; Pang X; Xue L; Lu S; Zhong M; Li J; Yu H; Lou D; Cui D; Xie X; Wang J;
    J Am Coll Cardiol; 2022 Aug; 80(6):584-594. PubMed ID: 35926931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
    Perry CM
    Am J Cardiovasc Drugs; 2012 Dec; 12(6):415-26. PubMed ID: 23181944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Ivabradine in Japanese Patients With Chronic Heart Failure　- J-SHIFT Study.
    Tsutsui H; Momomura SI; Yamashina A; Shimokawa H; Kihara Y; Saito Y; Hagiwara N; Ito H; Yano M; Yamamoto K; Ako J; Inomata T; Sakata Y; Tanaka T; Kawasaki Y;
    Circ J; 2019 Sep; 83(10):2049-2060. PubMed ID: 31391387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ivabradine, a novel medication for treatment of heart failure with reduced ejection fraction.
    Foster JL; Bobadilla RV
    J Am Assoc Nurse Pract; 2016 Nov; 28(11):576-582. PubMed ID: 27215699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ivabradine effects on heart rate and quality of life among chronic heart failure patients.
    Farooq F; Imran N; Abbas M
    J Pak Med Assoc; 2021 Jan; 71(1(A)):86-89. PubMed ID: 33484526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.